Roberto Paredes
Roberto Paredes
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,2,
Marion Schneider
Marion Schneider
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,2,
Adam Stevens
Adam Stevens
2Manchester Academic Health Science Centre, Manchester, UK
3Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health M13 9WL, University of Manchester, UK
2,3,
Daniel J White
Daniel J White
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Andrew J K Williamson
Andrew J K Williamson
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Joanne Muter
Joanne Muter
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Stella Pearson
Stella Pearson
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
James R Kelly
James R Kelly
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Kathleen Connors
Kathleen Connors
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Daniel H Wiseman
Daniel H Wiseman
2Manchester Academic Health Science Centre, Manchester, UK
4Leukaemia Biology Group, CRUK Manchester Institute, Manchester M20 4XB, UK
2,4,
John A Chadwick
John A Chadwick
2Manchester Academic Health Science Centre, Manchester, UK
4Leukaemia Biology Group, CRUK Manchester Institute, Manchester M20 4XB, UK
2,4,
Harald Löffler
Harald Löffler
5Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
5,3,
Hsiang Ying Teng
Hsiang Ying Teng
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Simon Lovell
Simon Lovell
2Manchester Academic Health Science Centre, Manchester, UK
6Evolution, Systems and Genomics Domain, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK
2,6,
Richard Unwin
Richard Unwin
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,3,
Henri J van de Vrugt
Henri J van de Vrugt
7Oncogenetics, Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
7,
Helen Smith
Helen Smith
2Manchester Academic Health Science Centre, Manchester, UK
6Evolution, Systems and Genomics Domain, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK
2,6,
Olga Kustikova
Olga Kustikova
8Institute of Experimental Hematology, Hannover Medical School; Hannover, Germany
8,
Axel Schambach
Axel Schambach
8Institute of Experimental Hematology, Hannover Medical School; Hannover, Germany
8,
Tim C P Somervaille
Tim C P Somervaille
2Manchester Academic Health Science Centre, Manchester, UK
4Leukaemia Biology Group, CRUK Manchester Institute, Manchester M20 4XB, UK
2,4,
Andrew Pierce
Andrew Pierce
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
1,2,
Anthony D Whetton
Anthony D Whetton
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
9Stoller Biomarker Discovery Centre, University of Manchester, Manchester M13 9NQ, UK
1,2,9,
Stefan Meyer
Stefan Meyer
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
10Department of Paediatric Haematology and Oncology, Royal Manchester Children's Hospital, Manchester M13 9WL, UK
11Young Oncology Unit, The Christie NHS Foundation Trust, Manchester M20 4XB, UK
1,2,10,11,✉
1Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Palatine Road, Manchester M20 3LI, UK
2Manchester Academic Health Science Centre, Manchester, UK
3Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health M13 9WL, University of Manchester, UK
4Leukaemia Biology Group, CRUK Manchester Institute, Manchester M20 4XB, UK
5Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
6Evolution, Systems and Genomics Domain, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK
7Oncogenetics, Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
8Institute of Experimental Hematology, Hannover Medical School; Hannover, Germany
9Stoller Biomarker Discovery Centre, University of Manchester, Manchester M13 9NQ, UK
10Department of Paediatric Haematology and Oncology, Royal Manchester Children's Hospital, Manchester M13 9WL, UK
11Young Oncology Unit, The Christie NHS Foundation Trust, Manchester M20 4XB, UK
✉To whom correspondence should be addressed. Tel: +44 161 446 3090; Fax: +44 161 446 3091; Email: stefan.meyer@manchester.ac.uk
2The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.
3Present addresses:
Richard Unwin, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Harald Löffler, Zentrum für Innere Medizin III, Marienhospital, Stuttgart, Germany.
© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com